Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (medicinal product) | true | Inferred relationship | Some | ||
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Live attenuated Human alphaherpesvirus 3 Oka strain antigen | true | Inferred relationship | Some | 1 | |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | quatre | false | Inferred relationship | Some | ||
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Live attenuated Measles morbillivirus Schwartz strain antigen | true | Inferred relationship | Some | 2 | |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated Rubella virus Wistar RA 27/3 strain (substance) | true | Inferred relationship | Some | 3 | |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Live attenuated Mumps orthorubulavirus Jeryl-Lynn RIT 4385 strain antigen | true | Inferred relationship | Some | 4 | |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Measles + mumps + rubella + varicella vaccine (product) | false | Inferred relationship | Some | ||
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Measles vaccine (substance) | false | Inferred relationship | Some | 3 | |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Mumps vaccine (substance) | false | Inferred relationship | Some | 4 | |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Rubella vaccine (substance) | false | Inferred relationship | Some | 1 | |
| PRIORIX-TETRA powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Varicella virus vaccine (substance) | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR